Please login to the form below
Bayer's Eylea cleared for wider use in Europe
Macular oedema treatment reached €759m in sales last year
J&J sells Cordis unit to Cardinal Health for $1.94bn
Marks J&J’s exit from the cardiovascular stent market
Complaints about UK medical advertising drop
And this year the MHRA will be vetting adverts to promote a ‘right first time’ approach
GSK public-private partnership CTTV names director
Centre for Therapeutic Target Validation launched last year
Novartis divests cancer drugs to bring GSK deal to completion
Array BioPharma picks up the Swiss companny's BRAF and MEK inhibitors
Amgen's Kyprolis tops Velcade in myeloma trial
Amgen hoping to topple Takeda’s $2bn a year drug
Sanofi’s Lantus follow-up nears European approval
CHMP backing for Toujeo follows hot on the heels of its US approval by the FDA
Greater Manchester to control its share of the NHS budget
The north-west English region accounts for 5% of the country's health spending
Jinarc backed for European approval in rare kidney disease
Positive opinion for Otsuka comes just before rare disease awareness day
Does 'trust leadership' feature in your strategy?
Pharma companies wanting to be more patient-focused will need to develop their people skills
-
2015: A year of promise and connectivityHow could technology impact healthcare in this year and what will be the key trends to follow?
-
Future gazing: What does 2015 hold for NICE?Undermined by the CDF, the Institute is set to face a number of challenges this year
-
UCB boosted by core medicines growthFirm’s new chief executive 'excited' by his company’s next batch of medicines
-
Sovaldi-Daklinza combo cures hep C in co-infected HIV patientsPhase III trial of BMS and Gilead antivirals cured 97% of patients
-
Gilead's Sovaldi wins NICE approval but faces access delayThe Institute also recommends Janssen's hepatitis C drug Olysio
-
Sanofi gets green light for Lantus follow-up ToujeoOnce-daily basal insulin gains FDA approval for diabetes
-
Actavis gets FDA nod for new antibioticAvycaz is the fifth antibiotic to gain US approval in recent months
-
BMS buys immunotherapy specialist Flexus in $1.2bn dealAnd signs new cancer research partnership with Rigel
-
Shire boosts orphan drug pipeline with Meritage Pharma dealFirm will also acquire global rights to Meritage’s phase III OBS compound
Latest appointments
-
Publicis Healthcare names North America group presidentAlexandra von Plato to take up the role
-
Ex Sanofi boss joins Boston start-upChris Viehbacher joins other industry veterans as the newest board member of PureTech
-
Cidara Therapeutics makes senior appointmentsPaul Daruwala and James Balkovec join the biotech
-
Peter Nightingale appointed as chair of new MHRA committeeWas formerly president of the Intensive Care Society
-
UCB CEO elected to the Ministerial Industry Strategy GroupJean-Christophe Tellier assumed the role of CEO on January 1
Featured jobs
- Director – Client Engagement – Brand Team - Reading, Berkshire...
-
Senior level salary + comprehensive benefits
- Healthcare PR Account Manager, Internal Communications
-
c£30-35,000 according to skills and experience
- Business Unit Director – Consumer Healthcare Advertising – South...
-
Very lucrative remuneration on offer
- Assistant Editor – Clinical Pharmacy: The Pharmaceutical Journal...
-
Competitive Salary Offered
- Experienced Medical Writer MILAN – ITALY – Medical Education – R...
-
Excellent Remuneration & Relocation Assistance
- Account Executive and Senior Account Executive NEEDED for FUN &...
-
Bonus + Benefits
- Associate Project Director – Meetings Management - Reading, Berk...
-
Competitive + excellent benefits
- AM or Senior Account Manager – Digital – Healthcare Advertising ...
-
EXTENSIVE PACKAGE AVAILABLE
- FREELANCE!! Account Manager / Senior Account Manager – TOP 5 Hea...
-
VERY COMPETITIVE DAY RATE
- Account Manager & Senior Account Manager – Medical Communica...
-
£33000 - £48000 + BONUS + BENEFITS
- Senior Medical Writer
-
Competitive Salary Offered
DGH Recruitment
Subscribe to our email news alerts
- Indian generics firm GVK set to be hit with European sales ban
- Boehringer in breach over beer drinking, lederhosen presentation
- Pharma firms violate marketing regulations every week, claims study
- Advagraf shows survival increase for liver transplant patients
- BMS buys immunotherapy specialist Flexus in $1.2bn deal
- Roche taps Qualcomm for remote health monitoring
PMHub
Red Door Unlimited
Red Door Unlimited is the health and wellbeing communications consultancy that lives and breathes originality and is built on `firsts'....
Latest intelligence
- Growing influence of pharmacists in the sale of Rx and OTC medicines
- Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
- Drivers of 2014′s Soaring Drug Approvals
- The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
- Russian innovation at the crossroads
- Despite improvements, investors face rising risks...
Quick links
